ItemPopulation genomics of pneumococcal carriage in South Africa following the introduction of the 13valent pneumococcal conjugate vaccine PCV13 immunizationNida Javaid; Courtney Olwagen; Susan Nzenze; Paulina Hawkins; Rebecca Gladstone; Lesley McGee; Shabir Madhi; E et al ItemEtiological Surveillance of Male Urethritis Syndrome in South Africa 2019 to 2020Ranmini Kularatne; V Maseko; P Mahlangu; E Muller; Tendesayi Kufa ItemNaringenin as a potential inhibitor of human cyclindependent kinase 6 Molecular and structural insights into anticancer therapeuticsMohd Yousuf; Anas Shamsi; Shama Khan; Parvez Khan; Moyad Shahwan; E et al ItemPsychological Distress in South African Healthcare Workers Early in the COVID19 Pandemic An Analysis of Associations and Mitigating FactorsH S Lee; Kerry Wilson; Colleen Bernstein; N Naicker; A Yassi; J M Spiegel ItemTime of HIV diagnosis CD4 count and viral load at antenatal care start and delivery in South AfricaDorina Onoya; Cornelius Nattey; Nelly Jinga; Constance Mongwenyana; Gayle Sherman ItemTime to embrace access programmes for medicines lessons from the South African flucytosine access programmeA Shroufi; Nelesh Govender; G Meintjes; John Black; Jeremy Nel; M Moosa; Colin Menezes; E et al ItemCryptococcus gattii Species Complex as an Opportunistic Pathogen Underlying Medical Conditions Associated with the InfectionDong-Hoon Yang; Matthew R England; Helene Salvator; Seher Anjum; E et al; Nelesh Govender ItemIn utero human cytomegalovirus infection is associated with increased levels of putatively protective maternal antibodies in nonprimary infection evidence for boosting but not protectionJeffrey Dorfman; Sashkia Balla; Jayani Pathirana; Michelle Groome; Shabir Madhi; Penelope Moore ItemPerceptions of risk and motivation for healthy living among immigrants from nonwestern countries with prior gestational diabetes mellitus living in DenmarkStine Bagger; Helle Terkildsen Maindal; Karoline Kragelund Nielsen; Amanda Gronbjer Vra; Jens Aagaard-Hansen ItemA Research and Development RD roadmap for influenza vaccines Looking toward the futureKristine A. Moore; Julia T. Ostrowsky; Alison M. Kraigsley; Angela J. Mehr; E et al; Cheryl Cohen ItemIntroduction to the Sitespecific Etiologic Results From the Pneumonia Etiology Research for Child Health PERCH StudyMaria D Knoll; Christine Prosperi; Henry C Bagget; W Abdullah Brooks; E et al; Shabir Madhi ItemMaintaining focus on administering effetive malaria treatment during the COVID 19 pandemicJaishree Raman; K Barnes; L Baker; M Blaylock; L Blumberg; John Frean; E Misiani; I Ukpe ItemEvaluation of the Aptima HIV1 Quant Dx assay for HIV diagnosis at birth in South AfricaAurelie Mukendi; Tendesayi Kufa; Gayle Sherman; Karl-Gunter Technau; Caroline Tiemessen; Ahmad Haeri Mazanderani ItemHIV1 resupression on a firstline regimen despite the prescence of phenotypic drug resistanceAdriaan Basson; Salome Charalambous; Christopher Hoffmann; Lynn Morris ItemCommunity perspectives on tuberculosis care in rural South AfricaJennifer Watermeyer; Myrtle Penn ItemEmerging differences between Huntingtons diseaselike 2 and Huntingtons disease A comparison using MRI brain volumetryDavid Anderson; Mark Haagensen; Aline Ferreira Correia; Pierson Ronald; J Carr; Amanda Krause; Russel Margolis ItemOdyssean malaria outbreaks in Gauteng Province, South Africa, 2007- 2013(2014-05) Frean, J; Brooke, B; Thomas, J; Blumberg, LBackground: Odyssean malaria refers to malaria transmitted by translocated mosquitoes and is a diagnosis of exclusion, as the probability of finding the responsible vector is miniscule. We believe that road traffic from endemic areas in and around South Africa is the source of most of the infected mosquitoes. Because of the unexpected nature of the disease, diagnosis is often delayed and severe and complicated malaria is common Objectives: To describe outbreaks of odyssean malaria during the period 2007 through 2013 in Gauteng Province, South Africa, and to educate healthcare workers about this form of malaria. Methods: Site visits, environmental hygiene inspections, patient interviews, and entomological investigations for adult mosquitoes and larvae in potential breeding sites were done in each identified outbreak. Results: Over the period, 14 laboratory-proven and 7 probable cases of odyssean malaria were investigated. There were 2 deaths (9.5% case fatality rate, approximately 10 times higher than the national fatality rate for malaria). We describe two recent clusters of cases in detail, and emphasise the importance of clinician awareness of this rare but frequently severe form of malaria. Conclusion. Odyssean malaria cases are inevitable in South Africa, given the volume of road, rail and air traffic from malaria risk areas into Gauteng and other non-endemic provinces. It is likely that many cases are missed, owing to the rare and sporadic nature of the condition. Malaria should always be kept in mind as a cause of unexplained fever and thrombocytopenia, even in the absence of a travel history ItemEffectiveness of pneumococcal conjugate vaccine and rotavirus vaccine introduction into the South African public immunisation programme(2014-03) Madhi, S.A; Bamford, L; Ngcobo, NImmunisation has contributed greatly to the control of vaccine-preventable diseases and therefore to improvements in health and survival, especially among young children, and remains one of the most successful and cost-effective public health interventions. This remains true for many of the newer, more expensive vaccines. Vaccines against invasive pneumococcal disease and rotavirus infection were introduced into the South African Expanded Programme on Immunization in April 2009. This article describes the rationale for and process of the introduction of these two vaccines, pneumococcal conjugate vaccine and rotavirus vaccine. It also aims to evaluate the success of and challenges related to their introduction, in terms of both achieving universal coverage and improving survival and health in South African children.